Keywords: 1st-half, sales, rise, ares-serono, worldwide, swiss, group

1st-Half Sales Rise 15% At Ares-Serono

Article | 02 September 1996

Worldwide sales at Swiss group Ares-Serono rose 15% in the first six months of 1996 to $375.9 million. Operating income grew 78.8% to $45.7 million, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Metrodin

Urofollitropin for Injection

Go to drug listing